About
David Roblin is a British physician, scientist, and biotech executive who serves as CEO and co-founder of Relation Therapeutics. He previously led R&D at Summit Therapeutics and was COO of the Francis Crick Institute after more than two decades in senior roles at Pfizer and Bayer. He also serves on biotech boards including Nxera Pharma and Centauri Therapeutics.
Areas of interest
biotechpharmaceuticalsdrug discoverytranslational medicineAImachine learninggenomicsosteoporosis